KARAVAS, Evangelos,KOUTRIS, Efthimios,SAMARA, Vasiliki,KOUTRI, Ioanna,KALASKANI, Anastasia,KAKOURIS, Andreas
申请号：
DK14718330
公开号：
DK2988735T3
申请日:
2014.04.17
申请国别(地区):
DK
年份:
2020
代理人:
摘要：
The present invention relates to a stable pharmaceutical formulation for oral administration comprising a therapeutically effective amount of a serotonin-norepinephrine reuptake inhibitor or a pharmaceutically acceptable salt thereof, in particular Duloxetine that inhibits degradation and/or hydrolysis of the active ingredient. It also relates to a process for the preparation thereof.
